Cargando…

Effectiveness of Risk Evaluation and Mitigation Strategies (REMS) for Lenalidomide and Thalidomide: Patient Comprehension and Knowledge Retention

INTRODUCTION: The effectiveness of patient education activities conducted within the lenalidomide and thalidomide risk evaluation and mitigation strategies (REMS) programs was evaluated by measuring understanding of serious risk and safe-use messages. METHODS: Results from mandatory knowledge, attit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brandenburg, Nancy A., Bwire, Robert, Freeman, John, Houn, Florence, Sheehan, Paul, Zeldis, Jerome B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362654/ https://www.ncbi.nlm.nih.gov/pubmed/28074423 http://dx.doi.org/10.1007/s40264-016-0501-2

Ejemplares similares

Therapy of Angiosarcoma with Thalidomide and Lenalidomide
por: Mattes, M. Jules, et al.
Publicado: (2021)

A Review of the Efficacy of Thalidomide and Lenalidomide in the Treatment of Refractory Prurigo Nodularis
por: Lim, Victoria M., et al.
Publicado: (2016)

Thalidomide and lenalidomide for recurrent ovarian cancer: A systematic review of the literature
por: Tempfer, Clemens B., et al.
Publicado: (2017)

Adherence to risk evaluation and mitigation strategies (REMS) requirements for monthly testing of liver function
por: Blanchette, Christopher M, et al.
Publicado: (2015)

Recent clinical studies of the immunomodulatory drug (IMiD®) lenalidomide
por: Bartlett, J B, et al.
Publicado: (2005)

Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial
por: Suichi, Tomoki, et al.
Publicado: (2020)

Implications of Risk Evaluation and Mitigation Strategy (REMS) Programs for Managed Care Pharmacy
por: Projects, AMCP Special
Publicado: (2012)

Development of Federally Mandated Risk Evaluation and Mitigation Strategies (REMS) for Transmucosal Immediate-Release Fentanyl Products
por: Pergolizzi, Joseph V, et al.
Publicado: (2013)

Restoration of immune surface molecules in Kaposi sarcoma-associated herpes virus infected cells by lenalidomide and pomalidomide
por: Davis, David A., et al.
Publicado: (2017)

The Xyrem(®) (Sodium Oxybate) Risk Evaluation and Mitigation Strategy (REMS) Program in the USA: Results From 2016 to 2017
por: Strunc, Michael J., et al.
Publicado: (2021)

Thalidomide—Then and Now: Case Report of a Woman With Thalidomide Embryopathy and Review of Current Thalidomide Uses
por: Malik, Sara, et al.
Publicado: (2021)

Rethinking thalidomide.
Publicado: (1995)

Thalidomide and neurotrophism
por: Soper, Judith R., et al.
Publicado: (2018)

Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma
por: Chen, Christine, et al.
Publicado: (2009)

Pragmatic applications of implementation science frameworks to regulatory science: an assessment of FDA Risk Evaluation and Mitigation Strategies (REMS) (2014–2018)
por: Huynh, Linda, et al.
Publicado: (2021)

Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma
por: Rosiñol, Laura, et al.
Publicado: (2023)

Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury
por: Lecca, Daniela, et al.
Publicado: (2023)

Physician and Pharmacist Understanding of the Risk of Urinary Retention with Retigabine (Ezogabine): A REMS Assessment Survey
por: Ishihara, Lianna, et al.
Publicado: (2015)

Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma
por: Stadtmauer, Edward A, et al.
Publicado: (2009)

Local Aspects of Avian Non-REM and REM Sleep
por: Rattenborg, Niels C., et al.
Publicado: (2019)

Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
por: Huang, Shang-Yi, et al.
Publicado: (2014)

B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review
por: Sinit, Ryan B., et al.
Publicado: (2019)

Exploring the impact of mifepristone’s risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics()
por: Razon, Na’amah, et al.
Publicado: (2022)

Thalidomide in Dermatology: Revisited
por: Hassan, Iffat, et al.
Publicado: (2015)

Death and Rebirth of the Thalidomide Molecule: A Case of Thalidomide-Induced Sensory Neuropathy
por: Kesserwani, Hassan
Publicado: (2021)

Comprehensive Knowledge of Reservoir Hosts is Key to Mitigating Future Pandemics
por: Zhu, Pingfen, et al.
Publicado: (2020)

Regulation of REM and Non-REM Sleep by Periaqueductal GABAergic Neurons
por: Weber, Franz, et al.
Publicado: (2018)

Assessing the role of REM13, REM34 and REM46 during the transition to the reproductive phase in Arabidopsis thaliana
por: Manrique, Silvia, et al.
Publicado: (2023)

The Antibody Molecule
por: Zeldis, Jerome
Publicado: (1976)

Trial Watch: Lenalidomide-based immunochemotherapy
por: Semeraro, Michaela, et al.
Publicado: (2013)

An amalgamated risk estimation model (REM) and assay integration into future REMs
por: Cartwright, Peter, et al.
Publicado: (2011)

PHARMACEUTICALS: New Insights into Thalidomide
por: Brown, Valerie J.
Publicado: (2009)

A history of thalidomide in India
por: Wimmelbücker, Ludger, et al.
Publicado: (2023)

P046 Knowledge of REM Behaviour Disorder Among Sleep Technicians in Australia
por: Coussens, S, et al.
Publicado: (2023)

Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma
por: Lund, Johan, et al.
Publicado: (2018)

Dictyostelium Discoideum: A Developmental System
por: Zeldis, Jerome B.
Publicado: (1976)

The Harvey Lectures: Series 69, 1973-1974
por: Zeldis, Jerome B.
Publicado: (1976)

Biochemistry
por: Zeldis, Jerome Bernard
Publicado: (1976)

The Effects of Sequencing Strategies in Teaching Methods on Nursing Students’ Knowledge Acquisition and Knowledge Retention
por: Lin, Wei-Ting, et al.
Publicado: (2022)

Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers
por: Bartlett, J B, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_bfpq5c3esno50fo5o5r725nob8